Nanodecoy system: A novel approach to design hepatitis B vaccine for immunopotentiation
Authors:
- Suresh P. VyasSVSuresh P. Vyas
- 1 February 2006
- journal article
- Published by Elsevier in International Journal of Pharmaceutics
- Vol. 309 (1-2) , 227-233
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Development of a single-dose stabilized poly(d,l-lactic-co-glycolic acid) microspheres-based vaccine against hepatitis BJournal of Pharmacy and Pharmacology, 2004
- INDUCTION OF TH1 AND TH2 CD4+T CELL RESPONSES:The Alternative ApproachesAnnual Review of Immunology, 1997
- Control of molecular polymorphisms by a structured carbohydrate / ceramic delivery vehicle — aquasomesJournal of Controlled Release, 1996
- Preservation of surface‐dependent properties of viral antigens following immobilization on particulate ceramic delivery vehiclesJournal of Biomedical Materials Research, 1995
- Hepatitis B Virus ImmunopathogenesisAnnual Review of Immunology, 1995
- Conformationally stabilizing self-assembling nanostructured delivery vehicles for biochemically reactive pairsNanostructured Materials, 1995
- Adjuvants for human vaccines—current status, problems and future prospectsVaccine, 1995
- Self-Assembling NanostructuresNature Biotechnology, 1993
- Adjuvants: current status, clinical perspectives and future prospectsImmunology Today, 1993
- Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4Nature, 1970